Oct 21, 2025 02:00AM
Oct 21, 2025 02:00AM
Aug 18, 2025 09:11AM
Aug 18, 2025 09:10AM
Jul 18, 2025 11:31AM
Jul 18, 2025 11:30AM
Jun 20, 2025 08:01AM SpringWorks Therapeutics (SWTX) Receives Positive CHMP Opinion for Nirogacestat for the Treatment of Adults with Desmoid Tumors
Jun 20, 2025 08:00AM
May 23, 2025 08:00AM
May 23, 2025 08:00AM
Apr 28, 2025 02:13AM
Apr 28, 2025 02:11AM
Apr 27, 2025 10:35AM
Apr 27, 2025 10:35AM SpringWorks Therapeutics Announces Expected CHMP Opinion in Q2 2025 for Nirogacestat for the Treatment of Adults with Desmoid Tumors in the European Union
Apr 24, 2025 03:32PM
Feb 20, 2025 06:30AM
Feb 19, 2025 08:00AM
Feb 11, 2025 08:20PM
Feb 11, 2025 05:32PM
Feb 11, 2025 05:27PM
Feb 11, 2025 03:45PM FDA approves SpringWorks' (SWTX) mirdametinib for adult and pediatric patients with neurofibromatosis type 1 who have symptomatic plexiform neurofibromas not amenable to complete resection
Jan 30, 2025 07:00AM
Jan 13, 2025 06:34AM
Jan 13, 2025 06:30AM
Jan 13, 2025 06:30AM
Jan 3, 2025 06:30AM
Nov 26, 2024 07:00AM
Nov 12, 2024 09:25AM SpringWorks Therapeutics to Participate in the Jefferies London Healthcare Conference
Nov 12, 2024 06:30AM
Nov 11, 2024 07:00AM
Nov 11, 2024 06:30AM
Nov 7, 2024 06:30AM
Nov 7, 2024 06:30AM
Nov 5, 2024 07:00AM
Oct 22, 2024 07:00AM SpringWorks Therapeutics to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
Sep 3, 2024 04:58AM
Aug 29, 2024 08:16AM
Aug 28, 2024 06:31AM
Aug 28, 2024 06:30AM
Aug 7, 2024 06:30AM
Jul 29, 2024 06:47AM
Jul 29, 2024 06:30AM SpringWorks Therapeutics Appoints Dr. Martin Mackay to its Board of Directors
Jul 23, 2024 07:00AM
Jul 2, 2024 02:30PM
Jul 1, 2024 06:31AM
Jul 1, 2024 06:30AM
Jun 5, 2024 07:00AM
May 23, 2024 05:13PM
May 8, 2024 07:00AM SpringWorks Therapeutics to Participate in the BofA Securities 2024 Health Care Conference
May 2, 2024 06:30AM

322,248 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All